The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
Open accessAbstract
BACKGROUND: Prehypertension is considered a precursor of stage 1 hypertension and a predictor of excessive cardiovascular risk. We investigated whether pharmacologic treatment of prehypertension prevents or postpones stage 1 hypertension. METHODS: Participants with repeated measurements of systolic pressure of 130 to 139 mm Hg and diastolic pressure of 89 mm Hg or lower, or systolic pressure of 139 mm Hg or lower and diastolic pressure of 85 to 89 mm Hg, were randomly assigned to receive two years of candesartan (Atacand, AstraZeneca) or placebo, followed by two years of placebo for all. When a participant reached the study end point of stage 1 hypertension, treatment with antihypertensive agents was initiated. Both the candesartan group and the placebo group were instructed to make changes in lifestyle to reduce blood pressure throughout the trial. RESULTS: A total of 409 participants were randomly assigned to candesartan, and 400 to placebo. Data on 772 participants (391 in the candesartan group and 381 in the placebo group; mean age, 48.5 years; 59.6 percent men) were available for analysis. During the first two years, hypertension developed in 154 participants in the placebo group and 53 of those in the candesartan group (relative risk reduction, 66.3 percent; P<0.001). After four years, hypertension had developed in 240 participants in the placebo group and 208 of those in the candesartan group (relative risk reduction, 15.6 percent; P<0.007). Serious adverse events occurred in 3.5 percent of the participants assigned to candesartan and 5.9 percent of those receiving placebo. CONCLUSIONS: Over a period of four years, stage 1 hypertension developed in nearly two thirds of patients with untreated prehypertension (the placebo group). Treatment of prehypertension with candesartan appeared to be well tolerated and reduced the risk of incident hypertension during the study period. Thus, treatment of prehypertension appears to be feasible. (ClinicalTrials.gov number, NCT00227318.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
Vasan, R. S., Larson, M. G., Leip, E. P., Evans, J. C., O'Donnell, C. J., Kannel, W. B., & Levy, D. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003417 · Cited by 2,082
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768
Whelton, P. K. (2002) · JAMA · doi:10.1001/jama.288.15.1882 · Cited by 1,473
Vasan, R. S., Larson, M. G., Leip, E. P., Kannel, W. B., & Levy, D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06710-1 · Cited by 1,072
Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 946
Panza, J. A., Casino, P. R., Kilcoyne, C. M., & Quyyumi, A. A. (1993) · Circulation · doi:10.1161/01.cir.87.5.1468 · Cited by 707
Mild High-Renin Essential Hypertension: Neurogenic Human Hypertension?
Esler, M., Julius, S., Zweifler, A., Randall, O., Harburg, E., Gardiner, H., & DeQuattro, V. (1977) · New England Journal of Medicine · doi:10.1056/nejm197702242960801 · Cited by 529
Self-citationHarrap, S. B., van der Merwe, W. M., Griffin, S. A., MacPherson, F., & Lever, A. F. (1990) · Hypertension · doi:10.1161/01.hyp.16.6.603 · Cited by 339
Greenlund, K. J., Croft, J. B., & Mensah, G. A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2113 · Cited by 324
Jennings, G., Nelson, L., Nestel, P., Esler, M., Korner, P., Burton, D., & Bazelmans, J. (1986) · Circulation · doi:10.1161/01.cir.73.1.30 · Cited by 301
Is Prehypertension a Risk Factor for Cardiovascular Diseases?
Qureshi, A. I., Suri, M. F. K., Kirmani, J. F., Divani, A. A., & Mohammad, Y. (2005) · Stroke · doi:10.1161/01.str.0000177495.45580.f1 · Cited by 294
Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels.
Hart, M. N., Heistad, D. D., & Brody, M. J. (1980) · Hypertension · doi:10.1161/01.hyp.2.4.419 · Cited by 256
Julius, S. (1990) · JAMA · doi:10.1001/jama.264.3.354 · Cited by 256
Self-citationHyperkinetic borderline hypertension in Tecumseh, Michigan
Julius, S., Krause, L., Schork, N. J., Mejia, A. D., Jones, K. A., van de Ven, C., Johnson, E. H., Sekkarie, M. A., Kjeldsen, S. E., Petrin, J., et al. (1991) · Journal of Hypertension · doi:10.1097/00004872-199101000-00012 · Cited by 248
Self-citationBorderline hypertension—A critical review
Julius, S., & Schork, M. A. (1971) · Journal of Chronic Diseases · doi:10.1016/0021-9681(71)90005-1 · Cited by 245
Self-citationPrehypertension and Cardiovascular Morbidity
Liszka, H. A. (2005) · The Annals of Family Medicine · doi:10.1370/afm.312 · Cited by 243
The Hypertension Prevention Trial: Three-Year Effects of Dietary Changes on Blood Pressure
Hypertension Prevention Trial Research Group (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390130131021 · Cited by 212
The cardiovascular continuum and renin–angiotensin–aldosterone system blockade
Dzau, V. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000165623.72310.dd · Cited by 207
Schiffrin, E. L., & Deng, L.-Y. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.699 · Cited by 192
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.
Egan, B., Panis, R., Hinderliter, A., Schork, N., & Julius, S. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113138 · Cited by 182
Self-citationImpact of high-normal blood pressure on the risk of cardiovascular disease
Vasan, R. S., Larson, M. G., & Leip, E. P. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00536-6 · Cited by 169
High-normal blood pressure progression to hypertension in the Framingham Heart Study.
Leitschuh, M., Cupples, L. A., Kannel, W., Gagnon, D., & Chobanian, A. (1991) · Hypertension · doi:10.1161/01.hyp.17.1.22 · Cited by 169
Qureshi, A. I., Suri, M. F. K., Kirmani, J. F., & Divani, A. A. (2005) · PubMed · Cited by 150
Schiffrin, E. L., Deng, L.-Y., & Larochelle, P. M. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)96211-2 · Cited by 142
Impact of systolic and diastolic blood pressure on cardiovascular mortality
Neaton, J., Kuller, L. H., Stamler, J. F., & Wentworth, D. N. (1995) · Cited by 100
Trial of Preventing Hypertension
Julius, S., Nesbitt, S. D., Egan, B. M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000130174.70055.ca · Cited by 58
Self-citationData and Safety Monitoring Boards
Friedman, L. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012274065-7/50008-3 · Cited by 48
Heredity and hypertension: Impact on metabolic characteristics
Neutel, J. M., Smith, D. H. G., Graettinger, W. F., Winer, R. L., & Weber, M. A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90610-8 · Cited by 47
Self-citationIs Low-Risk Hypertension Fact or Fiction?Cardiovascular Risk Profile in the TROPHY Study
NESBITT, S., Julius, S., LEONARD, D., Egan, B. M., & Grozinski, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.01.021 · Cited by 30
Self-citationCardiovascular and metabolic characteristics of hypertension
Weber, M. A., Smith, D. H. G., Neutel, J. M., & Graettinger, W. F. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90057-5 · Cited by 24
Self-citation
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Metadata
- Authors
- Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, H. R., Grimm, R. H., Messerli, F. H., Oparil, S., & Schork, M. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-04-20
- Volume
- 354
- Issue
- 16
- Pages
- 1685-1697
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2113176678
- Cited by
- 924
- References
- 34
- FWCI
- 70.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.